Literature DB >> 33796521

Age Conditional Probability of Ocular and Ocular Adnexal Malignancies.

Mathias Nittmann1, Curtis E Margo2.   

Abstract

AIM: The aim of this study was to discuss and illustrate the role age-conditional probability has in communicating risk of developing ocular and ocular adnexal malignancies.
METHODS: Cross-sectional incidence for retinoblastoma, uveal melanoma, conjunctival melanoma, and lacrimal gland carcinomas from 2000 to 2017 were obtained from the Surveillance, Epidemiology and End Results (SEER) database. Incidence rates were age-adjusted to the 2000 United States population. Age-adjusted incidence was converted to age-interval and cumulative risks. Outcomes were examined in 20-year intervals and cumulatively for adult cancers and yearly for retinoblastoma.
RESULTS: The risk of each malignancy displayed age-dependent variation. For adult malignancies, men were at higher risk at most age intervals. Uveal melanoma had the greatest cumulative lifetime risk. The probability of developing retinoblastoma declines precipitously after age 3 years.
CONCLUSIONS: Age-conditional probability of developing cancer is a conceptually friendly means of understanding and communicating risk. It is particularly useful in comparing the risks of uncommon or rare cancers, such as those found in and around the eye. The assessment of risk in terms of age-conditional probability is a versatile and an underutilized pedagogical tool.
Copyright © 2020 by S. Karger AG, Basel.

Entities:  

Keywords:  Cancer risk; Cumulative probability; Lacrimal gland carcinoma; Ocular adnexal cancer; Retinoblastoma; Risk assessment; Uveal melanoma

Year:  2020        PMID: 33796521      PMCID: PMC7989850          DOI: 10.1159/000511364

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  16 in total

1.  United States life tables, 1997.

Authors:  R N Anderson
Journal:  Natl Vital Stat Rep       Date:  1999-12-13

2.  Age adjustment using the 2000 projected U.S. population.

Authors:  R J Klein; C A Schoenborn
Journal:  Healthy People 2010 Stat Notes       Date:  2001-01

3.  Cancer statistics, 2019.

Authors:  Rebecca L Siegel; Kimberly D Miller; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2019-01-08       Impact factor: 508.702

4.  Cancer statistics, 2012.

Authors:  Rebecca Siegel; Deepa Naishadham; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2012-01-04       Impact factor: 508.702

5.  Measuring the public health burden of cancer in the United States through lifetime and age-conditional risk estimates.

Authors:  R M Merrill; D L Weed
Journal:  Ann Epidemiol       Date:  2001-11       Impact factor: 3.797

Review 6.  Cancer survival and incidence from the Surveillance, Epidemiology, and End Results (SEER) program.

Authors:  Lynn A Gloeckler Ries; Marsha E Reichman; Denise Riedel Lewis; Benjamin F Hankey; Brenda K Edwards
Journal:  Oncologist       Date:  2003

7.  Estimating lifetime and age-conditional probabilities of developing cancer.

Authors:  L M Wun; R M Merrill; E J Feuer
Journal:  Lifetime Data Anal       Date:  1998       Impact factor: 1.588

Review 8.  Words or numbers? Communicating risk of adverse effects in written consumer health information: a systematic review and meta-analysis.

Authors:  Roland Brian Büchter; Dennis Fechtelpeter; Marco Knelangen; Martina Ehrlich; Andreas Waltering
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-26       Impact factor: 2.796

9.  Uveal Melanoma: 5-Year Update on Incidence, Treatment, and Survival (SEER 1973-2013).

Authors:  Mary E Aronow; Allan K Topham; Arun D Singh
Journal:  Ocul Oncol Pathol       Date:  2017-10-13

10.  What is the lifetime risk of developing cancer?: the effect of adjusting for multiple primaries.

Authors:  P D Sasieni; J Shelton; N Ormiston-Smith; C S Thomson; P B Silcocks
Journal:  Br J Cancer       Date:  2011-07-19       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.